Home › Core › ISCC-IDs › 28C489x1ETk5P

View ISCC-ID

Core Data

28C489x1ETk5P
ISCC-ID - digital asset identifier
CCc1tHumEkkJP-CTYoQS7wHiXW2-CD4Ftn3iKUw9s-CRYPWqEKGFTmh
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

resurrection of parp inhibitors in breast cancer

Ledger Reference

coblo
Source Ledger/Blockchain
12402898
N-th ISCC Decleration on source ledger
31487d70258ae0644c2416af5b76580b3b5970647c869e23ad2d235a178f164b
Hash of block that includes the ISCC-DECLARATION
70f98868c2425d8ebe4f929d513da0f39919da6b78285f214f1d0225cfcd7805
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Resurrection of PARP Inhibitors in Breast Cancer", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Tomas G. Lyons", "@type": "Person"}, {"name": "Mark E. Robson", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://jnccn.org/downloadpdf/journals/jnccn/16/9/article-p1150.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Harborside Press, LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.6004/jnccn.2018.7031", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCc1tHumEkkJP-CTYoQS7wHiXW2-CD4Ftn3iKUw9s-CRYPWqEKGFTmh", "propertyID": "ISCC"}], "datePublished": "2018-09-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close